• Investing Insights & Exclusive Offers → Get Our FREE “Market Brief”
    Sign-up for our free weekly newsletter. Get unparalleled investing insights and exclusive Summer Sale discounts on Hedgeye research.

    Disclaimer: By joining our email marketing list you agree to receive marketing emails from Hedgeye. You may unsubscribe at any time by clicking the unsubscribe link in one of the emails. Use of Hedgeye and any other products available through hedgeye.com are subject to our Terms Of Service and Privacy Policy

Watch the replay below as Healthcare analyst Tom Tobin and Health Policy analyst Emily Evans review their sector's current Position Monitor and more! 

 CLICK HERE to access the associated slides.


  • Position Monitor Updates - DVA down and SGRY and CERN removed.
  • Machine Learning - We’re developing machine learning techniques to expand our toolkit for measuring “what’s in the stock” for our current positions, as well as screen for new ideas.
  • Davita Inc (DVA) - Despite maintaining 2019 Guidance, there are significant caveats. What the end of a roll-up looks like continues to reveal itself.
  • DexCom, Inc. (DXCM) - Growth is good but unlikely to be durable, particularly as they split new patient market share with ABT’s Freestyle Libre.
  • EXACT Sciences Corporation (EXAS) - Adoption curves are durable, upside case may be baked in in the near term. Is stalking the long term a credible threat?
  • Live Q&A